Graphene/Nafion Composite Film Modified Glassy Carbon Electrode for Simultaneous Determination of Paracetamol, Aspirin and Caffeine in Pharmaceutical Formulations
dc.authorid | Senturk, Zuhre/0000-0002-0356-9345 | |
dc.authorid | Levent, Abdulkadir/0000-0001-5792-419X | |
dc.authorid | Yardim, Yavuz/0000-0002-9587-096X | |
dc.authorid | Celebi, Metin/0000-0003-1475-8878 | |
dc.authorscopusid | 57188666717 | |
dc.authorscopusid | 55511747958 | |
dc.authorscopusid | 25951378700 | |
dc.authorscopusid | 6602133530 | |
dc.authorscopusid | 7004177719 | |
dc.authorwosid | Senturk, Zuhre/Aas-5179-2020 | |
dc.authorwosid | Levent, Abdulkadir/V-5418-2017 | |
dc.authorwosid | Celebi, Metin/Gwd-1423-2022 | |
dc.contributor.author | Yigit, Aydin | |
dc.contributor.author | Yardim, Yavuz | |
dc.contributor.author | Celebi, Metin | |
dc.contributor.author | Levent, Abdulkadir | |
dc.contributor.author | Senturk, Zuhre | |
dc.date.accessioned | 2025-05-10T17:41:00Z | |
dc.date.available | 2025-05-10T17:41:00Z | |
dc.date.issued | 2016 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Yigit, Aydin; Yardim, Yavuz] Yuzuncu Yil Univ, Dept Analyt Chem, Fac Pharm, TR-65080 Van, Turkey; [Celebi, Metin] Yuzuncu Yil Univ, Dept Inorgan Chem, Fac Sci, TR-65080 Van, Turkey; [Levent, Abdulkadir] Batman Univ, Hlth Serv Vocat Coll, TR-72100 Batman, Turkey; [Senturk, Zuhre] Yuzuncu Yil Univ, Dept Analyt Chem, Fac Sci, TR-65080 Van, Turkey | en_US |
dc.description | Senturk, Zuhre/0000-0002-0356-9345; Levent, Abdulkadir/0000-0001-5792-419X; Yardim, Yavuz/0000-0002-9587-096X; Celebi, Metin/0000-0003-1475-8878 | en_US |
dc.description.abstract | A graphene-Nafion composite film was fabricated on the glassy carbon electrode (GR-NF/GCE), and used for simultaneous determination of paracetamol (PAR), aspirin (ASA) and caffeine (CAF). The electrochemical behaviors of PAR, ASA and CAF were investigated by cyclic voltammetry and square-wave adsorptive anodic stripping voltammetry. By using stripping one for simultaneous determination of PAR, ASA and CAF, their electrochemical oxidation peaks appeared at +0.64,1.04 and 1.44 V, and good linear current responses were obtained with the detection limits of 18 ng mL(-1) (1.2 x 10(-9) M), 11.7 ng mL(-1) (6.5 x 10(-8) M) and 7.3 ng mL(-1) (3.8 x 10(-8) M), respectively. Finally, the proposed electrochemical sensor was successfully applied for quantifying PAR, ASA and CAF in commercial tablet formulations. (C) 2016 Elsevier B.V. All rights reserved. | en_US |
dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [KBAG114Z405] | en_US |
dc.description.sponsorship | The authors gratefully acknowledge financial support from The Scientific and Technological Research Council of Turkey (TUBITAK) (Project number: KBAG114Z405). | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1016/j.talanta.2016.05.046 | |
dc.identifier.endpage | 29 | en_US |
dc.identifier.issn | 0039-9140 | |
dc.identifier.issn | 1873-3573 | |
dc.identifier.pmid | 27343573 | |
dc.identifier.scopus | 2-s2.0-84970027928 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 21 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.talanta.2016.05.046 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/15380 | |
dc.identifier.volume | 158 | en_US |
dc.identifier.wos | WOS:000379370400004 | |
dc.identifier.wosquality | Q1 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Paracetamol | en_US |
dc.subject | Aspirin | en_US |
dc.subject | Caffeine | en_US |
dc.subject | Graphene-Nafion Composite Film Modified Glassy Carbon Electrode | en_US |
dc.subject | Pharmaceutical Formulation | en_US |
dc.title | Graphene/Nafion Composite Film Modified Glassy Carbon Electrode for Simultaneous Determination of Paracetamol, Aspirin and Caffeine in Pharmaceutical Formulations | en_US |
dc.type | Article | en_US |